bullish•Giant Biogene Holding•23 Nov 2023 16:22
2024 High Conviction - Giant Biogene - Growth Rate Keeps Moving Higher
Giant Biogene was listed in Hong Kong IPO in 2022. It has done well since and is now trading 45% above its IPO price, but its still cheap.
bullish•Bloomage Biotechnology Lt•21 Jan 2021 09:45
Bloomage Biotechnology (688363.CH) - Accelerated Growth with the Approval of New Regulation
The article analyzed Bloomage in terms of major business (raw material, medical products, functional skin care and functional food after the new...
bearish•Giant Biogene Holding•02 May 2023 09:57
Giant Biogene IPO Lock-Up - US$1.7bn Lockup Release Will Increase Free Float by 14x
Giant Biogene raised around US$70m in its Hong Kong IPO, after having downsized the deal and priced it at the low-end. Its six-month lockup will...
bullish•Honasa Consumer•07 Nov 2023 09:55
Honasa Consumer IPO Trading - Great Anchor Book, Not so Great Overall Demand. Loved by FIIs
Honasa Consumer (Honasa IN) raised about US$200m in its India IPO. In this note, we talk about the deal updates and the trading dynamics.
bullish•Honasa Consumer•30 Oct 2023 11:25